Daewoong, Up 24.27% on Rising Theme of COVID-19 (Treatment/Vaccine Development)

On the 11th, the COVID-19 (treatment/vaccine development, etc.) theme rose 3.04% compared to the previous day, showing strength, while Daewoong, a related stock attracting attention, surged 24.27% compared to the previous day. Daewoong is known as a holding company specializing in investments related to healthcare and the bio industry.

[Graph] Major stock price changes in the COVID-19 (treatment/vaccine development, etc.) theme

According to provisional data compiled at 11:26, foreigners are net selling 83,800 shares of Daewoong, while institutions are net buying 31,000 shares.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Daewoong ranks 2nd out of 25 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as Daewoong having relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.